Search

everythinglearnresearchcommunity

for

Search:↓

Azathioprine may be an effective treatment for severe hair loss.

Azathioprine treatment led to rapid hair regrowth in a woman with alopecia universalis.

Antiyeast treatments work better for seborrheic dermatitis than steroids, and other findings include increased skin bacteria under plastic wrap, a nasal cell defect in Staphylococcus aureus carriers, quick resolution of certain skin reactions, high rubber latex allergy in spina bifida patients, and glyceryl monopentadecanoate's effectiveness for male hair loss.

Isotretinoin effectively treats severe acne but has serious side effects and requires careful monitoring.

Minoxidil 2% effectively treats female hair loss, promoting growth and density.

Photodynamic therapy was effective in treating multiple scalp basal cell carcinomas with minimal side effects and good cosmetic results.

Myotonic dystrophy should be considered in patients with hair thinning, and genetic counseling is important.

Microneedling may improve quality of life and reduce inflammation in frontal fibrosing alopecia.

A woman had temporary hair loss due to stress from a spinal cord injury.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Nitrogen mustard was not very effective for hair regrowth in alopecia areata and has potential skin cancer risk.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Ayurvedic treatment effectively cured a boy's alopecia areata with no side effects or recurrence.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Baricitinib effectively regrows hair in severe alopecia areata cases.

Early detection and tailored treatment of lupus nephritis are crucial to prevent kidney damage.

The Li-Pa/Ca and Do/Ca chemotherapy regimens for serous ovarian cancer showed better short-term and long-term results than the Pa/Ca regimen.

New skin treatments in 1987-1988 showed effectiveness for various conditions, but some had side effects or risks.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

Proactive physical therapy improved mobility, reduced fatigue, and pain in lupus patients.

Anti-CD19 therapy may help treat SLE and NMOSD.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Imiquimod 5% cream reduced equine sarcoids in most cases.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

Topical minoxidil effectively and safely treats extensive alopecia areata but doesn't change its course.